Human herpes virus 6 reactivation: important predictor for poor outcome after myeloablative, but not non-myeloablative allo-SCT.
de Pagter PJ, Schuurman R, Keukens L, Schutten M, Cornelissen JJ, van Baarle D, Fries E, Sanders EA, Minnema MC, van der Holt BR, Meijer E, Boelens JJ.
de Pagter PJ, et al. Among authors: van der holt br, van baarle d.
Bone Marrow Transplant. 2013 Nov;48(11):1460-4. doi: 10.1038/bmt.2013.78. Epub 2013 Jun 17.
Bone Marrow Transplant. 2013.
PMID: 23771003